{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:21:21Z","timestamp":1790457681752,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T00:00:00Z","timestamp":1562112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"2018 key R&D plan in Shandong province","award":["2018GSF118138"],"award-info":[{"award-number":["2018GSF118138"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5850-7","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T08:02:59Z","timestamp":1562140979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"Yingjie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juandong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,3]]},"reference":[{"key":"5850_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"5850_CR2","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","volume":"381","author":"A Pennathur","year":"2013","unstructured":"Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013;381:400\u201312.","journal-title":"Lancet"},{"issue":"6","key":"5850_CR3","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1097\/SLA.0b013e3182565b0b","volume":"255","author":"YK Vashist","year":"2012","unstructured":"Vashist YK, Effenberger KE, Vettorazzi E, et al. Disseminated tumor cells in bone marrow and the natural course of resected esophageal cancer. Ann Surg. 2012;255(6):1105\u201312.","journal-title":"Ann Surg"},{"key":"5850_CR4","doi-asserted-by":"crossref","unstructured":"Su PJ, Wu MH, Wang HM, et al. Circulating tumor cells as an independent prognostic factor in patients with advanced oesophageal squamous cell carcinoma undergoing chemoradiotherapy. Sci Rep. 2016(17);6:31423.","DOI":"10.1038\/srep31423"},{"issue":"7","key":"5850_CR5","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3748\/wjg.v23.i7.1310","volume":"23","author":"Hai-Tao Xu","year":"2017","unstructured":"Xu HT, Miao J, Liu JW, et al. Prognostic value of circulating tumor cells in esophageal cancer. World J Gastroenterol. 2017, 21;23(7):1310\u20131318.","journal-title":"World Journal of Gastroenterology"},{"issue":"11","key":"5850_CR6","doi-asserted-by":"publisher","first-page":"8053","DOI":"10.2147\/OTT.S175855","volume":"12","author":"J Hou","year":"2018","unstructured":"Hou J, Zou K, Yang C, et al. Clinicopathological and prognostic significance of circulating tumor cells in patients with esophageal cancer: a meta-analysis. Onco Targets Ther. 2018;12(11):8053\u201361.","journal-title":"Onco Targets Ther"},{"key":"5850_CR7","doi-asserted-by":"crossref","unstructured":"Li Y, Zhang X, Liu D, et al. Dynamic acquisition of HER2 expression on circulating tumor cells in gastric cancer patients correlates to developing therapeutic resistance. 2017.","DOI":"10.1158\/1538-7445.AM2017-3795"},{"key":"5850_CR8","unstructured":"Ilie M, Hofman V, Long E, et al. Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine? Annals of translational medicine 2014; 2(11)."},{"key":"5850_CR9","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1200\/JCO.2007.14.2364","volume":"25","author":"L Harris","year":"2007","unstructured":"Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, Taube S, Somerfield MR, Hayes DF, Bast RC. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25:5287\u2013312.","journal-title":"J Clin Oncol"},{"key":"5850_CR10","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/bjs.5717","volume":"94","author":"T Setoyama","year":"2007","unstructured":"Setoyama T, Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Aikou T. Isolated tumour cells in blood and E-cadherin expression in oesophageal squamous cell cancer. Br J Surg. 2007;94:984\u201391.","journal-title":"Br J Surg"},{"key":"5850_CR11","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10585-009-9274-7","volume":"26","author":"M Cao","year":"2009","unstructured":"Cao M, Yie SM, Wu SM, Chen S, Lou B, He X, Ye SR, Xie K, Rao L, Gao E, Ye NY. Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance. Clinical & experimental metastasis. 2009;26:751\u20138.","journal-title":"Clinical & experimental metastasis"},{"key":"5850_CR12","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1111\/j.1349-7006.2011.01926.x","volume":"102","author":"S Matsusaka","year":"2011","unstructured":"Matsusaka S, Suenaga M, Mishima Y, et al. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer. Cancer Sci. 2011;102:1188\u201392.","journal-title":"Cancer Sci"},{"key":"5850_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/bjc.2015.417","volume":"114","author":"Y Li","year":"2016","unstructured":"Li Y, Gong J, Zhang Q, et al. Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer. Br J Cancer. 2016;114:138\u201345.","journal-title":"Br J Cancer"},{"key":"5850_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1126\/science.aaf6546","volume":"352","author":"KJ Cheung","year":"2016","unstructured":"Cheung KJ, Ewald AJ. A collective route to metastasis: seeding by tumor cell clusters. Science. 2016;352:167\u20139.","journal-title":"Science"},{"issue":"1","key":"5850_CR15","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.1038\/s41598-017-10763-7","volume":"7","author":"PP Lin","year":"2017","unstructured":"Lin PP, Gires O, Wang DD, et al. Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells. Sci Rep. 2017;7(1):9789.","journal-title":"Sci Rep"},{"key":"5850_CR16","doi-asserted-by":"crossref","first-page":"15639","DOI":"10.18632\/oncotarget.3712","volume":"6","author":"J Jiang","year":"2015","unstructured":"Jiang J, Wang DD, Yang M, et al. Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model. Oncotarget. 2015;6:15639\u201351.","journal-title":"Oncotarget"},{"key":"5850_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00535-014-0961-z","volume":"50","author":"JJ Hao","year":"2015","unstructured":"Hao JJ, Yao HQ, Dai GY, et al. Chromosomal aneuploidies and combinational fluorescence in situ hybridization probe panels are useful for predicting prognosis for esophageal squamous cell carcinoma. J Gastroenterol. 2015;50:155\u201366.","journal-title":"J Gastroenterol"},{"key":"5850_CR18","doi-asserted-by":"publisher","first-page":"7377","DOI":"10.1007\/s00216-013-7156-y","volume":"405","author":"R Ran","year":"2013","unstructured":"Ran R, Li L, Wang M, Wang S, Zheng Z, Lin PP. Determination of EGFR mutations in single cells microdissected from enriched lung tumor cells in peripheral blood. Anal Bioanal Chem. 2013;405:7377\u201382.","journal-title":"Anal Bioanal Chem"},{"key":"5850_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/JTO.0b013e3181914125","volume":"4","author":"C Wu","year":"2009","unstructured":"Wu C, Hao H, Li L, Zhou X, Guo Z, Zhang L, Zhang X, Zhong W, Guo H, Bremner RM, Lin P. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients. J Thorac Oncol. 2009;4:30\u20136.","journal-title":"J Thorac Oncol"},{"key":"5850_CR20","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1158\/0008-5472.CAN-10-3604","volume":"71","author":"AJ Lee","year":"2011","unstructured":"Lee AJ, Endesfelder D, Rowan AJ, Walther A, Birkbak NJ, Futreal PA, Downward J, Szallasi Z, Tomlinson IP, Howell M, Kschischo M, Swanton C. Chromosomal instability confers intrinsic multidrug resistance. Cancer Res. 2011;71:1858\u201370.","journal-title":"Cancer Res"},{"key":"5850_CR21","doi-asserted-by":"publisher","first-page":"812","DOI":"10.18632\/oncotarget.1026","volume":"4","author":"M Auer","year":"2013","unstructured":"Auer M, Heitzer E, Ulz P, et al. Single circulating tumor cell sequencing for monitoring. Oncotarget. 2013;4:812\u20133.","journal-title":"Oncotarget"},{"key":"5850_CR22","doi-asserted-by":"publisher","first-page":"21083","DOI":"10.1073\/pnas.1320659110","volume":"110","author":"X Ni","year":"2013","unstructured":"Ni X, Zhuo M, Su Z, et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci. 2013;110:21083\u20138.","journal-title":"Proc Natl Acad Sci"},{"key":"5850_CR23","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1126\/science.aab0917","volume":"349","author":"DT Miyamoto","year":"2015","unstructured":"Miyamoto DT, Zheng Y, Wittner BS, et al. RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance. Science. 2015;349:1351\u20136.","journal-title":"Science."},{"key":"5850_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1586\/14737159.2016.1116942","volume":"16","author":"F Salvianti","year":"2016","unstructured":"Salvianti F, Pazzagli M, Pinzani P. Single circulating tumor cell sequencing as an advanced tool in cancer management. Expert Rev Mol Diagn. 2016;16:51\u201363.","journal-title":"Expert Rev Mol Diagn"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5850-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5850-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5850-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T19:33:31Z","timestamp":1593632011000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5850-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,3]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5850"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5850-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,3]]},"assertion":[{"value":"28 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Human Research Ethical Committee of the Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, Shandong, with protocol No.KYLL-2019 (LW)-001. Written informed consent was obtained from each participants included in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"651"}}